Sulfamethoxazole is metabolized to the hydroxylamine in humans

Delayed Drug Hypersensitivity Reactions

Pichler, W. J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-8-200310210-00012 · Cited by 737 · see citing works

Idiosyncratic drug reactions: the reactive metabolite syndromes

Knowles, S. R., Uetrecht, J., & Shear, N. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03137-8 · Cited by 331 · see citing works

Idiosyncratic Adverse Drug Reactions: Current Concepts

Uetrecht, J., & Naisbitt, D. J. (2013) · Pharmacological Reviews · doi:10.1124/pr.113.007450 · Cited by 308 · see citing works

Pharmacological interaction of drugs with antigen-specific immune receptors: the p-i concept

Pichler, W. J. (2002) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200208000-00003 · Cited by 309 · see citing works

Drug-Induced Methaemoglobinaemia Treatment Issues

Coleman, M. D., & Coleman, N. A. (1996) · Drug Safety · doi:10.2165/00002018-199614060-00005 · Cited by 275 · see citing works

Cutaneous Drug Reactions

Svensson, C. K., Cowen, E. W., & Gaspari, A. A. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01501-1 · Cited by 274 · see citing works

Biotransformation of sulfamethoxazole by microalgae: Removal efficiency, pathways, and mechanisms

Chu, Y., Zhang, C., Wang, R., Chen, X., Ren, N., & Ho, S. (2022) · Water Research · doi:10.1016/j.watres.2022.118834 · Cited by 253 · see citing works

HLA-restricted, processing- and metabolism-independent pathway of drug recognition by human alpha beta T lymphocytes.

Zanni, M. P., von Greyerz, S., Schnyder, B., Brander, K. A., Frutig, K., Hari, Y., Valitutti, S., & Pichler, W. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3544 · Cited by 238 · see citing works

Pharmacological Interaction of Drugs with Immune Receptors: The p-i Concept

Pichler, W. J., Beeler, A., Keller, M., Lerch, M., Posadas, S. J., Schmid, D. A., Spanou, Z., Gschwend, A., & Gerber, B. O. (2006) · Allergology International · doi:10.2332/allergolint.55.17 · Cited by 232 · see citing works

Biodegradation of sulfamethoxazole and other sulfonamides by Achromobacter denitrificans PR1

Reis, P. J. M., Reis, A. C., Ricken, B., Kolvenbach, B. A., Manaia, C. M., Corvini, P. F.-X., & Nunes, O. C. (2014) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2014.08.039 · Cited by 221 · see citing works

Drug-induced liver disease

Chitturi, S., & Farrell, G. C. (2000) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-000-0034-7 · Cited by 221 · see citing works

Recognition of Sulfamethoxazole and Its Reactive Metabolites by Drug-Specific CD4+ T Cells from Allergic Individuals

Schnyder, B., Burkhart, C., Frutig, K., von Greyerz, S., Naisbitt, D. J., Pirmohamed, M., Park, B. K., & Pichler, W. J. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6647 · Cited by 212 · see citing works

Non-activated peroxymonosulfate oxidation of sulfonamide antibiotics in water: Kinetics, mechanisms, and implications for water treatment

Ji, Y., Lu, J., Wang, L., Jiang, M., Yang, Y., Yang, P., Zhou, L., Ferronato, C., & Chovelon, J. (2018) · Water Research · doi:10.1016/j.watres.2018.09.037 · Cited by 206 · see citing works

Biodegradation of antibiotics: The new resistance determinants – part I

Reis, A. C., Kolvenbach, B. A., Nunes, O. C., & Corvini, P. F.-X. (2019) · New Biotechnology · doi:10.1016/j.nbt.2019.08.002 · Cited by 193 · see citing works

Immune pathomechanism of drug hypersensitivity reactions

Pichler, W. J., Naisbitt, D. J., & Park, B. K. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.11.048 · Cited by 186 · see citing works

The Biochemistry of Drug Metabolism – An Introduction

Testa, B., & Krämer, S. D. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790032 · Cited by 177 · see citing works

Molecular mechanisms of CD8+ T cell–mediated delayed hypersensitivity: Implications for allergies, asthma, and autoimmunity

Kalish, R. S., & Askenase, P. W. (1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70489-6 · Cited by 153 · see citing works

Covalent binding of the nitroso metabolite of sulfamethoxazole leads to toxicity and major histocompatibility complex-restricted antigen presentation

Naisbitt, D. J., Farrell, J., Gordon, S. F., Maggs, J. L., Burkhart, C., Pichler, W. J., Pirmohamed, M., & Park, B. K. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.628 · Cited by 141 · see citing works

Immunological Principles of Adverse Drug Reactions

Naisbitt, D. J., Gordon, S. F., Pirmohamed, M., & Park, B. (2000) · Drug Safety · doi:10.2165/00002018-200023060-00002 · Cited by 142 · see citing works

Cellular and Molecular Pathophysiology of Cutaneous Drug Reactions

Pichler, W. J., Yawalkar, N., Britschgi, M., Depta, J. P. H., Strasser, I., Schmid, S., Kuechler, P. C., & Naisbitt, D. J. (2002) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200203040-00001 · Cited by 136 · see citing works

Antigenicity and immunogenicity of sulphamethoxazole: demonstration of metabolism‐dependent haptenation and T‐cell proliferation <i>in vivo</i>

Naisbitt, D. J., Gordon, S. F., Pirmohamed, M., Burkhart, C., Cribb, A. E., Pichler, W. J., & Park, B. K. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704074 · Cited by 133 · see citing works

Stimulation of human T cells with sulfonamides and sulfonamide metabolites

Castrejón-Flores, J. L., Berry, N. G., El-Ghaiesh, S. H., Gerber, B. O., Pichler, W. J., Park, B. K., & Naisbitt, D. J. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.10.031 · Cited by 130 · see citing works

Sulfonamide hypersensitivity

Slatore, C. G., & Tilles, S. A. (2004) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2004.03.011 · Cited by 121 · see citing works

Serum sickness–like reactions to cefaclor: Role of hepatic metabolism and individual susceptibility

KEARNS, G., Wheeler, J. G., Childress, S. H., & Letzig, L. G. (1994) · The Journal of Pediatrics · doi:10.1016/s0022-3476(06)80187-3 · Cited by 117 · see citing works

Lymphocyte Activation in Cutaneous Drug Reactions

Hertl, M., & Merk, H. F. (1995) · Journal of Investigative Dermatology · doi:10.1038/jid.1995.19 · Cited by 109 · see citing works

Performance and mechanism of sulfamethoxazole removal in different bioelectrochemical technology-integrated constructed wetlands

Liu, X., Lu, S., Liu, Y., Wang, Y., Guo, X., Chen, Y., Zhang, J., & Wu, F. (2021) · Water Research · doi:10.1016/j.watres.2021.117814 · Cited by 106 · see citing works

Drug bioactivation and protein adduct formation in the pathogenesis of drug-induced toxicity

Park, B. K., Laverty, H., Srivastava, A., Antoine, D. J., Naisbitt, D. J., & Williams, D. P. (2010) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2010.09.011 · Cited by 102 · see citing works

Influence of reduced glutathione on the proliferative response of sulfamethoxazole‐specific and sulfamethoxazole‐metabolite‐specific human CD4+ T‐cells

Burkhart, C., von Greyerz, S., Depta, J. P. H., Naisbitt, D. J., Britschgi, M., Park, K. B., & Pichler, W. J. (2001) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703845 · Cited by 95 · see citing works

Role of T cells in drug allergies

Pichler, W. J., Schnyder, B., Zanni, M. P., Hari, Y., & von Greyerz, S. (1998) · Allergy · doi:10.1111/j.1398-9995.1998.tb03881.x · Cited by 95 · see citing works

The p-i Concept: Pharmacological Interaction of Drugs With Immune Receptors

Pichler, W. J. (2008) · World Allergy Organization Journal · doi:10.1097/wox.0b013e3181778282 · Cited by 90 · see citing works

Immune mechanism of drug hypersensitivity

Pichler, W. J. (2004) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2004.03.012 · Cited by 91 · see citing works

Comparison of the In Vitro Cytotoxicity of Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone

Reilly, T. P., Bellevue, F. H., Woster, P. M., & Svensson, C. K. (1998) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)00547-9 · Cited by 90 · see citing works

Drug-induced bile duct injury

Visentin, M., Lenggenhager, D. M., Gai, Z., & Kullak-Ublick, G. A. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.033 · Cited by 88 · see citing works

The Generation, Detection, and Effects of Reactive Drug Metabolites

Stachulski, A. V., Baillie, T. A., Park, B. K., Obach, R. S., Dalvie, D., Williams, D. P., Srivastava, A., Regan, S., Antoine, D. J., Goldring, C. E., et al. (2012) · Medicinal Research Reviews · doi:10.1002/med.21273 · Cited by 88 · see citing works

Improvingthe decision-making process in structural modification of drug candidates: reducing toxicity

Nassar, A.-E. F., Kamel, A. M., & Clarimont, C. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(04)03297-0 · Cited by 84 · see citing works

Living with sulfonamides: a diverse range of mechanisms observed in bacteria

Nunes, O. C., Manaia, C. M., Kolvenbach, B. A., & Corvini, P. F.-X. (2020) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-020-10982-5 · Cited by 83 · see citing works

N-acetyltransferases: Pharmacogenetics and clinical consequences of polymorphic drug metabolism

Spielberg, S. P. (1996) · Journal of Pharmacokinetics and Biopharmaceutics · doi:10.1007/bf02353477 · Cited by 81 · see citing works

Sulfonamide cross-reactivity: Is there evidence to support broad cross-allergenicity?

Wulf, N. R., & Matuszewski, K. A. (2013) · American Journal of Health-System Pharmacy · doi:10.2146/ajhp120291 · Cited by 79 · see citing works

Immunochemical analysis of sulfonamide drug allergy: Identification of sulfamethoxazole-substituted human serum proteins

Meekins, C. V., Sullivan, T. J., & Gruchalla, R. S. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90120-1 · Cited by 76 · see citing works

Role of Viral Infections in the Induction of Adverse Drug Reactions

Levy, M. (1997) · Drug Safety · doi:10.2165/00002018-199716010-00001 · Cited by 76 · see citing works

Recognition and Management of Severe Cutaneous Drug Reactions

Knowles, S. R., & Shear, N. H. (2007) · Dermatologic Clinics · doi:10.1016/j.det.2007.01.011 · Cited by 75 · see citing works

Reactive metabolites and their role in drug reactions

Naisbitt, D. J., Williams, D. P., Pirmohamed, M., Kitteringham, N. R., & Park, B. K. (2001) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200108000-00007 · Cited by 69 · see citing works

Cytotoxicity of sulfonamide reactive metabolites: apoptosis and selective toxicity of CD8 + cells by the hydroxylamine of sulfamethoxazole

Hess, D. A., Sisson, M. E., Suria, H., Wijsman, J. A., Puvanesasingham, R., Madrenas, J., & Rieder, M. J. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.13.1688 · Cited by 65 · see citing works

Mechanisms of Unpredictable Adverse Drug Reactions

Rieder, M. J. (1994) · Drug Safety · doi:10.2165/00002018-199411030-00005 · Cited by 65 · see citing works

Role of polymorphic and monomorphic human arylamine N-acetyltransferases in determining sulfamethoxazole metabolism

Cribb, A. E., Nakamura, H., Grant, D. M., Miller, M. A., & Spielberg, S. P. (1993) · Biochemical Pharmacology · doi:10.1016/0006-2952(93)90280-a · Cited by 62 · see citing works

Impacts and fate of triclosan and sulfamethoxazole in intensified re-circulating vertical flow constructed wetlands

Button, M., Cosway, K., Sui, J., & Weber, K. P. (2018) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2018.08.395 · Cited by 64 · see citing works

Biodegradation of sulfamethoxazole by a bacterial consortium of Achromobacter denitrificans PR1 and Leucobacter sp. GP

Reis, A. C., Čvančarová, M., Liu, Y., Lenz, M., Hettich, T., Kolvenbach, B. A., Corvini, P. F.-X., & Nunes, O. C. (2018) · Applied Microbiology and Biotechnology · doi:10.1007/s00253-018-9411-9 · Cited by 64 · see citing works

Role of bioactivation in drug-induced hypersensitivity reactions

Sanderson, J. P., Naisbitt, D. J., & Park, B. K. (2006) · The AAPS Journal · doi:10.1208/aapsj080107 · Cited by 61 · see citing works

Toxicophores: groups and metabolic routes associated with increased safety risk.

Williams, D. P., & Naisbitt, D. J. (2002) · PubMed · Cited by 62 · see citing works

Mixed first and zero order kinetics in the electrooxidation of sulfamethoxazole at a boron-doped diamond (BDD) anode

Li, S., Bejan, D., McDowell, M. S., & Bunce, N. J. (2007) · Journal of Applied Electrochemistry · doi:10.1007/s10800-007-9413-2 · Cited by 62 · see citing works

Reactive oxygen species generation and its role in the differential cytotoxicity of the arylhydroxylamine metabolites of sulfamethoxazole and dapsone in normal human epidermal keratinocytes

Vyas, P. M., Roychowdhury, S., Woster, P. M., & Svensson, C. K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.023 · Cited by 61 · see citing works

Sulfonamide-reactive lymphocytes detected at very low frequency in the peripheral blood of patients with drug-induced eruptions

Kalish, R. S., LaPorte, A., Wood, J. A., & Johnson, K. L. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90202-x · Cited by 60 · see citing works

Cellular mechanisms of T cell mediated drug hypersensitivity

Gerber, B. O., & Pichler, W. J. (2004) · Current Opinion in Immunology · doi:10.1016/j.coi.2004.09.016 · Cited by 59 · see citing works

Plasma Cysteine Deficiency and Decreased Reduction of Nitrososulfamethoxazole with HIV Infection

Naisbitt, D. J., Vilar, F. J., Stalford, A. C., Wilkins, E. G. L., Pirmohamed, M., & Park, B. K. (2000) · AIDS Research and Human Retroviruses · doi:10.1089/088922200750054657 · Cited by 59 · see citing works

The importance of hapten–protein complex formation in the development of drug allergy

Faulkner, L., Meng, X., Park, B. K., & Naisbitt, D. J. (2014) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0000000000000078 · Cited by 57 · see citing works

Systematic suspect screening and identification of sulfonamide antibiotic transformation products in the aquatic environment

Majewsky, M., Glauner, T., & Horn, H. (2015) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-015-8748-5 · Cited by 57 · see citing works

Methemoglobin Formation by Hydroxylamine Metabolites of Sulfamethoxazole and Dapsone: Implications for Differences in Adverse Drug Reactions

Reilly, T., Woster, P. M., & Svensson, C. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38046-2 · Cited by 57 · see citing works

Immediate‐type hypersensitivity drug reactions

Stone, S. F., Phillips, E. J., Wiese, M. D., Heddle, R. J., & Brown, S. G. A. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12297 · Cited by 53 · see citing works

A chemically inert drug can stimulate T cells in vitro by their T cell receptor in non-sensitised individuals

Engler, O. B., Strasser, I., Naisbitt, D. J., Cerny, A., & Pichler, W. J. (2004) · Toxicology · doi:10.1016/j.tox.2003.12.008 · Cited by 54 · see citing works

Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.

van der Ven, A., Mantel, M., Vree, T. B., Koopmans, P., & van der Meer, J. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04339.x · Cited by 52 · see citing works

Biodegradation and metabolic pathway of sulfamethoxazole by Sphingobacterium mizutaii

Song, J., Hao, G., Liu, L., Zhang, H., Zhao, D., Li, X., Yang, Z., Xu, J., Ruan, Z., & Mu, Y. (2021) · Scientific Reports · doi:10.1038/s41598-021-02404-x · Cited by 53 · see citing works

Sulfamethoxazole degradation by Pseudomonas silesiensis F6a isolated from bioelectrochemical technology-integrated constructed wetlands

Liu, X., Chen, J., Liu, Y., Wan, Z., Guo, X., Lu, S., & Qiu, D. (2022) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2022.113698 · Cited by 50 · see citing works

Urinary recovery and kinetics of sulphamethoxazole and its metabolites in HIV-seropositive patients and healthy volunteers after a single oral dose of sulphamethoxazole

van der Ven, A., Vree, T., van Ewijk‐Beneken Kolmer, E., Koopmans, P., & van der Meer, J. (1995) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1995.tb05721.x · Cited by 45 · see citing works

Enhanced antigenicity leads to altered immunogenicity in sulfamethoxazole-hypersensitive patients with cystic fibrosis

Elsheikh, A., Castrejón-Flores, J. L., Lavergne, S. N., Whitaker, P., Monshi, M. M., Callan, H., El-Ghaiesh, S. H., Farrell, J., Pichler, W. J., Peckham, D. G., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1119 · Cited by 46 · see citing works

Noncovalent interactions of drugs with immune receptors may mediate drug-induced hypersensitivity reactions

Gerber, B. O., & Pichler, W. J. (2006) · The AAPS Journal · doi:10.1208/aapsj080119 · Cited by 48 · see citing works

Bioactivation, protein haptenation, and toxicity of sulfamethoxazole and dapsone in normal human dermal fibroblasts

BHAIYA, P., Roychowdhury, S., Vyas, P. M., Doll, M. A., Hein, D. W., & Svensson, C. K. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.02.006 · Cited by 48 · see citing works

Reactive Metabolites and Adverse Drug Reactions: Clinical Considerations

Knowles, S. R., Shapiro, L. E., & Shear, N. H. (2003) · Clinical Reviews in Allergy & Immunology · doi:10.1385/criai:24:3:229 · Cited by 48 · see citing works

Differential pulse voltammetric determination and catalytic oxidation of sulfamethoxazole using [5,10,15,20‐ tetrakis (3‐methoxy‐4‐hydroxy phenyl) porphyrinato] Cu (II) modified carbon paste sensor

Joseph, R., & Kumar, K. G. (2010) · Drug Testing and Analysis · doi:10.1002/dta.129 · Cited by 46 · see citing works

Patients with Delayed-Onset Sulfonamide Hypersensitivity Reactions Have Antibodies Recognizing Endoplasmic Reticulum Luminal Proteins

Cribb, A. E., Pohl, L. R., Spielberg, S. P., & Leeder, J. S. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36874-0 · Cited by 46 · see citing works

Mechanisms of drug reactions: The metabolic track

Shapiro, L. E., & Shear, N. H. (1996) · Seminars in Cutaneous Medicine and Surgery · doi:10.1016/s1085-5629(96)80034-4 · Cited by 45 · see citing works

Structure Toxicity Relationships - How Useful Are They in Predicting Toxicities of New Drugs?

Nelson, S. D. (2001) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0667-6_4 · Cited by 44 · see citing works

Topical provocation in 31 cases of fixed drug eruption: change of causative drugs in 10 years

Lee, A. (1998) · Contact Dermatitis · doi:10.1111/j.1600-0536.1998.tb05739.x · Cited by 43 · see citing works

Monitoring Adverse Drug Reactions to Sulfonamide Antibiotics in Human Immunodeficiency Virus–Infected Individuals

Neuman, M. G., Malkiewicz, I. M., Phillips, E. J., Rachlis, A., Ong, D., Yeung, E., & Shear, N. H. (2002) · Therapeutic Drug Monitoring · doi:10.1097/00007691-200212000-00008 · Cited by 40 · see citing works

Inhibition of sulfamethoxazole hydroxylamine formation by fluconazole in human liver microsomes and healthy volunteers*

Mitra, A., Thummel, K. E., Kalhorn, T. F., Kharasch, E. D., Unadkat, J. D., & Slattery, J. T. (1996) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(96)80011-7 · Cited by 40 · see citing works

Antigen processing: The gateway to the immune response

Kalish, R. S. (1995) · Journal of the American Academy of Dermatology · doi:10.1016/0190-9622(95)90351-8 · Cited by 39 · see citing works

Sulfonamide Hypersensitivity

Chow, T. G., & Khan, D. A. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08872-3 · Cited by 38 · see citing works

Predictive drug allergy testing: an alternative viewpoint

Pichler, W. J. (2001) · Toxicology · doi:10.1016/s0300-483x(00)00399-1 · Cited by 37 · see citing works

Drug hapten‐specific T‐cell activation: Current status and unanswered questions

Adair, K., Meng, X., & Naisbitt, D. J. (2021) · PROTEOMICS · doi:10.1002/pmic.202000267 · Cited by 37 · see citing works

The arylamine N-acetyltransferase (NAT2) polymorphism and the risk of adverse reactions to co-trimoxazole in children

Zielińska, M., Niewiarowski, W., & Bodalski, J. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050551 · Cited by 35 · see citing works

Genetically Determined Adverse Drug Reactions Involving Metabolism

Lennard, M. S. (1993) · Drug Safety · doi:10.2165/00002018-199309010-00006 · Cited by 35 · see citing works

Recurrent Headache as the Main Symptom of Acquired Cerebral Toxoplasmosis in Nonhuman Immunodeficiency Virus-infected Subjects With no Lymphadenopathy

PRANDOTA, J. (2007) · American Journal of Therapeutics · doi:10.1097/01.mjt.0000208272.42379.aa · Cited by 34 · see citing works

4-nitroso-sulfamethoxazole generation in soil under denitrifying conditions: Field observations versus laboratory results

Brienza, M., Duwig, C., Pérez, S., & Chirón, S. (2017) · Journal of Hazardous Materials · doi:10.1016/j.jhazmat.2017.04.015 · Cited by 33 · see citing works

Cross-reactivity with drugs at the T cell level

Depta, J. P. H., & Pichler, W. J. (2003) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/00130832-200308000-00005 · Cited by 33 · see citing works

Genotyping of the arylamine N-acetyltransferase polymorphism in the prediction of idiosyncratic reactions to trimethoprim-sulfamethoxazole in infants.

Zielińska, M., Bodalski, J., Mianowska, K., Niewiarowski, W., Rębowski, G., Skrętkowicz, J., & Sekulska, M. (1998) · Pharmacy World & Science · doi:10.1023/a:1008664707825 · Cited by 32 · see citing works

Adverse Reactions to Cotrimoxazole in HIV-infected Patients: Predictive Factors and Subsequent HIV Disease Progression

Rabaud, C., Charreau, I., Izard, S., Raffi, F., Meiffrédy, V., Leport, C., Guillemin, F., Yéni, P., & Aboulker, J.-P. (2001) · Scandinavian Journal of Infectious Diseases · doi:10.1080/003655401317074581 · Cited by 32 · see citing works

Reduction of Sulfamethoxazole Hydroxylamine (SMX-HA) by the Mitochondrial Amidoxime Reducing Component (mARC)

Ott, G., Plitzko, B., Krischkowski, C., Reichmann, D., Bittner, F., Mendel, R. R., Kunze, T., Clement, B., & Havemeyer, A. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500174u · Cited by 31 · see citing works

Role of Oxidative Stress in Hypersensitivity Reactions to Sulfonamides

Elzagallaai, A. A., Sultan, E. A., Bend, J. R., Abuzgaia, A. M., Loubani, E., & Rieder, M. J. (2019) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.1535 · Cited by 31 · see citing works

Plasma Ascorbate Deficiency Is Associated With Impaired Reduction of Sulfamethoxazole-Nitroso in HIV Infection

Trepanier, L. A., Yoder, A. R., Bajad, S. U., Beckwith, M. D., Bellehumeur, J. L., & Graziano, F. M. (2004) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200408150-00007 · Cited by 31 · see citing works

Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection

Lin, D., TUCKER, M., & Rieder, M. J. (2006) · Annals of Pharmacotherapy · doi:10.1345/aph.1g525 · Cited by 31 · see citing works

Drug skin metabolites and allergic drug reactions

Merk, H. F. (2009) · Current Opinion in Allergy and Clinical Immunology · doi:10.1097/aci.0b013e32832dd13c · Cited by 30 · see citing works

Characterization of Peroxidases Expressed in Human Antigen Presenting Cells and Analysis of the Covalent Binding of Nitroso Sulfamethoxazole to Myeloperoxidase

Ogese, M. O., Jenkins, R. E., Maggs, J. L., Meng, X., Whitaker, P., Peckham, D. G., Faulkner, L., Park, B. K., & Naisbitt, D. J. (2014) · Chemical Research in Toxicology · doi:10.1021/tx500458k · Cited by 29 · see citing works

Structural considerations on the selectivity of an immunoassay for sulfamethoxazole

Hoffmann, H., Baldofski, S., Hoffmann, K., Flemig, S., Silva, C. P., Esteves, V. I., Emmerling, F., Panne, U., & Schneider, R. J. (2016) · Talanta · doi:10.1016/j.talanta.2016.05.049 · Cited by 29 · see citing works

Definition of Haptens Derived from Sulfamethoxazole: In Vitro and in Vivo

Tailor, A., Waddington, J. C., Hamlett, J., Maggs, J., Kafu, L., Farrell, J., Dear, G. J., Whitaker, P., Naisbitt, D. J., Park, K., et al. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00282 · Cited by 26 · see citing works

Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris.

Bhambri, S., Rosso, J. Q. D., & Desai, A. (2007) · PubMed · Cited by 25 · see citing works

Delayed hypersensitivity reactions to sulphonamides: syndromes, pathogenesis and management

Trepanier, L. A. (1999) · Veterinary Dermatology · doi:10.1046/j.1365-3164.1999.00173.x · Cited by 25 · see citing works

T cells in drug allergy

Pichler, W. J. (2002) · Current Allergy and Asthma Reports · doi:10.1007/s11882-002-0032-z · Cited by 23 · see citing works

Is Hydroxylamine-Induced Cytotoxicity a Valid Marker for Hypersensitivity Reactions to Sulfamethoxazole in Human Immunodeficiency Virus-Infected Individuals?

Reilly, T. P., MacArthur, R. D., Farrough, M. J., Crane, L. R., Woster, P. M., & Svensson, C. K. (1999) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)35246-2 · Cited by 23 · see citing works

Lymphocyte Activation in Cutaneous Drug Reactions.

Hertl, M., & Merk, H. F. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12316127 · Cited by 22 · see citing works

Phenotypic diversity in delayed drug hypersensitivity: an immunologic explanation.

Meth, M. J., & Sperber, K. E. (2006) · PubMed · Cited by 22 · see citing works

Novel Clinical Biomarkers for Drug-Induced Liver Injury

Chen, Y., Guan, S., Guan, Y., Tang, S., Zhou, Y., Wang, X., Bi, H., & Huang, M. (2021) · Drug Metabolism and Disposition · doi:10.1124/dmd.121.000732 · Cited by 21 · see citing works

Hepatic microsomal metabolism of sulfamethoxazole to the hydroxylamine

Cribb, A. E., & Spielberg, S. P. (1990) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(25)08652-0 · Cited by 65 · see citing works

Short Communication Nonenzymatic Formation of a Novel Hydroxylated Sulfamethoxazole Derivative in Human Liver Microsomes:

Bioanalysis, I., & Metabolites, S. (2008)

Nonenzymatic formation of a novel hydroxylated sulfamethoxazole derivative in human liver microsomes: implications for bioanalysis of sulfamethoxazole metabolites

Sanderson, J. P., Hollis, F. J., Maggs, J. L., Clarke, S. E., Naisbitt, D. J., & Park, B. K. (2008) · Drug Metabolism and Disposition · doi:10.1124/dmd.108.021246 · Cited by 8 · see citing works

Formation and elimination of sulphamethoxazole hydroxylamine after oral administration of sulphamethoxazole.

van der Ven, A., Mantel, M., Vree, T. B., Koopmans, P., & van der Meer, J. (1994) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1994.tb04339.x · Cited by 52 · see citing works

Synthesis and in vitro toxicity of hydroxylamine metabolites of sulfonamides.

Rieder, M. J., Uetrecht, J., Shear, N. H., & Spielberg, S. P. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)24502-5 · Cited by 148 · see citing works